Agilent Technologies

Agilent Technologies, Inc (A) (Q4FY23) – Declining sales and rising costs squeeze margins

Highlights of the report

Agilent Technologies, a global leader in scientific products and services, has witnessed a surge in its stock price, driving valuations to unprecedented levels.

CrispIdea equity reports provide valuable insights to investors who may be individuals and organizations involved in the world of finance and investment like private equity houses, broking firms, hedge funds, investment advisory firms, mutual funds, banks and corporations. This research report is useful for M&A, business & investment analysis to all students and researchers also.


CrispIdea equity reports include basic financials, strategic analysis, competitive landscape assessments, stock performance, stock analysis and future growth potential evaluation. CrispIdea utilizes a proprietary blend of fundamental and technical analysis, offering a unique perspective. Reports present clear investment recommendations (“BUY,” “HOLD,” or “SELL”).


Our established reputation and track record advocates that our research carries weight within the investment community. Do connect with us, if you are looking for customized research, equity valuation, recommendation, analysis and market recommendation for any specific company, sector and industry.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide

Agilent’s revenue has decreased by (9% )to $1.68bn in Q4FY23 from $1.84bn in Q4FY22, COGS as % of sales has increased to 46% in Q4FY23 from 45% in Q4FY22 and on a yearly basis it has increased to 49.1% in FY23 from 45.6% in FY22.

Over the last 3 months Agilent Technologies stock has generated return of 24.53%, the price of stock has increased to $130.10 on 31st Jan 2024 from $104.47 on 2nd Nov 2023.



– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– Key Metrics
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance


Stock Price Performance

Crispidea Coverage

Report details

Agilent Technologies, Inc (A) (Q4FY23) – Declining sales and rising costs squeeze margins



Company Reports

Sector Reports